Tommaso Toffanin, MD, PhD

  • 4Articles
  • 31.6KReads1
  • 2020–2022Active
  • 10Collaborators
  • 33Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

Tommaso Toffanin, MD, PhD, is affiliated with Padua University Hospital in Padua, Italy. The author's publications from 2020 to 2022 focus on schizophrenia and schizoaffective disorders, cardiology, psychopharmacology, and women's health. Specific topics include QTc prolongation in acute psychiatric settings, long-acting aripiprazole for managing violence in schizophrenia, ovarian stimulation in bipolar disorder, and psychosis related to COVID-19 quarantine. The author has collaborated frequently with Benedetta Salvati, Chiara Pavan, Giorgio Pigato, Alessandro Miola, and Angela Favaro.

Publications

PCC
QTc Prolongation in Psychiatric Hospitalization
Original Research

QTc Prolongation in Psychiatric Hospitalization

February 17, 2022

QTc prolongation increases the risk of severe ventricular arrhythmias, in particular torsades de pointes. This study measured the prevalence of QTc prolongation in inpatients with severe mental illness to...
, , , et al
PCC
Case Report

Long-Acting Aripiprazole and Violence Management in Schizophrenia

January 14, 2021

Long-acting injectable aripiprazole is a viable treatment for patients with psychosis and violent conduct due to its behavioral and cognitive effects. Read this case report to find out more.
, , , et al
PCC
Case Report

Ovarian Stimulation for Infertility in a Woman With Bipolar Disorder

December 3, 2020

Women with bipolar disorder are vulnerable to mood episodes and postpartum psychosis due to pregnancy. This report describes the management of a woman with bipolar I disorder undergoing multiple...
, ,
PCC
Case Report

Psychosis and COVID-19-Related Quarantine

May 14, 2020

This report describes 3 clinical cases of patients admitted to the psychiatric ward following the enactment of quarantine measures in Italy during the COVID-19 pandemic. Read on to find...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe